Articles

January 26, 2022 Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row. Read More ›
December 21, 2021 Alnylam Publishes 2021 Patient Access Philosophy Report Alnylam has published its 2021 Patient Access Philosophy Report detailing its actions as a company to provide access to its medicines for those who may... Read More ›
December 16, 2021 Guest Post: Creating Connections to Support the hATTR Amyloidosis Community Susanne Berglund is the Chancellor of FAMY Norrbotten, an amyloidosis patient advocacy group reflects on the importance of making connections to support... Read More ›
December 2, 2021 Alnylam Named #1 Largest Employer in MA for 2021 by The Boston Globe Alnylam was named to The Boston Globe's Top Places to Work list for the 7th year in a row and the #1 company in the Largest employer category. Read More ›
October 29, 2021 Alnylam Named a Science Magazine Top Employer for 3rd Year in a Row Alnylam has been named to Science magazine's 2021 Top Employers list - our third year in a row on the list and ranking in the top 5 companies. Read More ›
October 28, 2021 Alnylam Names Dr. Yvonne Greenstreet New CEO Dr. Yvonne Greenstreet, currently Alnylam's President and COO, has been named Alnylam's new CEO effective year-end 2021, taking over from Dr. John Maraganore. Read More ›
October 13, 2021 Alnylam Challengers - a Health Equity Community Impact Program Alnylam Challengers is Alnylam's signature CSR Community Impact Program. It aims to improve health access to underserved communities. Read More ›
September 28, 2021 Alnylam Named a Best Workplace for Working Mothers and Fathers Alnylam has been named a 100 Best Companies (formerly Working Mother's Top 100 Companies) and Best Companies for Dads lists for 2021. Find out why. Read More ›
September 6, 2021 Co-Creating with Patients, for Patients: Addressing Unmet Needs in Conversations about AT ... Collaborating with patient organizations and patients is an essential part of our efforts to support people living with a complex rare disease like... Read More ›
September 4, 2021 Guest Post: Tracking My hATTR Amyloidosis Symptoms to Take Back Control David, from the UK, is living with hereditary ATTR amyloidosis. In this article, he discusses how he's using the STAR Symptom Tracker App to track his symptoms Read More ›
Subscribe to Articles